• Users Online: 279
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2020| July-September  | Volume 7 | Issue 3  
    Online since September 1, 2020

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
REVIEW ARTICLES
Immuno-potentiating effects of Astragalus polysaccharides: A mini-literature review
Hung- Chih Lai, Jo- Pai Chen
July-September 2020, 7(3):99-104
DOI:10.4103/JCRP.JCRP_3_20  
  389 86 -
ORIGINAL ARTICLES
Efficacy and safety of uracil-tegafur in patients with recurrent or metastatic thymic carcinoma
Shih- Yu Huang, Cheng- Hua Huang, Harvey Yu-Li Su, Yen- Hao Chen, Tai- Jan Chiu, Yen- Yang Chen
July-September 2020, 7(3):111-115
DOI:10.4103/JCRP.JCRP_11_20  
  368 72 -
SHORT COMMUNICATION
Management options for gynecological cancers in low- to middle-income countries amidst COVID-19 pandemic
Ashutosh Mishra, MD Ray, Sandeep Bhoriwal, Jyoti Sharma, Chitresh Kumar, Kunal Dhall, Manoj S Gowda, Akash Kumar
July-September 2020, 7(3):121-126
DOI:10.4103/JCRP.JCRP_14_20  
  351 52 -
REVIEW ARTICLES
Vascular onco-therapies targeting continuous and intermittent intra-tumor hypoxia
Tanmoy Paul, Sharmita Basu
July-September 2020, 7(3):105-110
DOI:10.4103/JCRP.JCRP_9_20  
  273 69 -
ORIGINAL ARTICLES
Oncological and renal function outcome in children with unilateral wilms' tumors treated with nephron sparing surgery or ablative nephrectomy
RB Nerli, Manas Sharma, Shridhar C Ghagane, Sreeharsha Nutalapati, Murigendra B Hiremath, Neeraj S Dixit
July-September 2020, 7(3):116-120
DOI:10.4103/JCRP.JCRP_12_20  
  197 52 -
CASE REPORTS
Gemcitabine/cisplatin/pembrolizumab-induced posterior reversible encephalopathy syndrome
Yuh- Ching Gau, Hui- Ching Wang, Hui- Hua Hsiao, Yi- Chang Liu
July-September 2020, 7(3):127-129
DOI:10.4103/JCRP.JCRP_6_20  
  137 34 -
Successfully overcoming carboplatin hypersensitivity by continuous 48-h infusion of cisplatin plus poly (ADP-ribose) polymerase inhibitor for heavily pretreated recurrent ovarian cancer
Yu- Mei Zheng, Jyh- Ming Chow, Chia- Lun Chang, Gi- Ming Lai
July-September 2020, 7(3):134-137
DOI:10.4103/JCRP.JCRP_16_20  
  135 25 -
Primary adenocarcinoma of the urinary bladder: Report of two cases with a literature review
Tsung- Jang Yeh, Shih- Hao Tang, Yi- Chang Liu, Hui- Hua Hsiao
July-September 2020, 7(3):130-133
DOI:10.4103/JCRP.JCRP_17_20  
  116 27 -